StageZero and DiagnoseAtHome to offer blood test in US and Canada
The test identifies gene expression profiles that indicate specific cancers by interrogating mRNA from a whole blood sample.
deal
Latest in
deal
Pancryos enters licence agreement for macroencapsulation device
The device was shown to boost survival and insulin secretion of cells in preclinical models.
Abbott, CamDiab and Ypsomed to develop automated insulin delivery system
The solution will incorporate Abbott’s FreeStyle Libre 3 sensor, CamDiab's CamAPS FX algorithm and Ypsomed’s mylife YpsoPump.
Wallaby acquires German company phenox for $543m
The merged company could become a leader in offering various neurovascular technologies and solutions globally.
Bearpac and APR Medtech sign pump drainage system supply deal in UK
The system comprises a Passio catheter, handheld control unit and disposable collection kit.
Eurofins and Cornell University to commercialise Covid-19 patients assays
The test uses cfDNA to measure the damage that Covid-19 inflicts on organs, cells and tissues.
Deals relating to China’s socioeconomic impact increased significantly in the medical industry in H2 2021
During second half of 2021, deals relating to China's socioeconomic impact accounted for 14.5% of all deals taking place in…
By
Illumina and Agendia to co-develop in vitro diagnostic tests for oncology
The platform will enable the expansion of various gene panels that are available to analyse solid tumours.